CASI PHARMACEUTICALS, INC. Operating Income
CASI PHARMACEUTICALS, INC. reported Operating Income of -$34.03 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-04-26
- CASI PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2022-12-31 was -$12.64M.
- CASI PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2022-09-30 was -$6.35M.
- CASI PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2022-06-30 was -$7.75M.
- CASI PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2022-03-31 was -$7.29M.
- CASI PHARMACEUTICALS, INC. operating income (loss) for fiscal 2019 was -$46.96M.
- CASI PHARMACEUTICALS, INC. operating income (loss) for fiscal 2018 was -$27.19M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | -$12.64M derived: 20-F 12 month − 10-Q 9 month · filed 2023-04-26 | -$19.00M derived: sum of 2 quarters · filed 2023-04-26 | -$26.74M derived: sum of 3 quarters · filed 2023-04-26 | -$34.03M 20-F · filed 2023-04-26 | |
| 2022-09-30 | -$6.35M 10-Q · filed 2022-11-14 | -$14.10M derived: sum of 2 quarters · filed 2022-11-14 | -$21.39M 10-Q · filed 2022-11-14 | -$32.44M derived: sum of 4 quarters · filed 2023-04-26 | |
| 2022-06-30 | -$7.75M 10-Q · filed 2022-08-12 | -$15.04M 10-Q · filed 2022-08-12 | -$26.09M derived: sum of 3 quarters · filed 2023-04-26 | -$32.98M derived: sum of 4 quarters · filed 2023-04-26 | |
| 2022-03-31 | -$7.29M 10-Q · filed 2022-05-12 | -$18.34M derived: sum of 2 quarters · filed 2023-04-26 | -$25.23M derived: sum of 3 quarters · filed 2023-04-26 | -$33.21M derived: sum of 4 quarters · filed 2023-04-26 | |
| 2021-12-31 | -$11.05M derived: 20-F 12 month − 10-Q 9 month · filed 2023-04-26 | -$17.94M derived: sum of 2 quarters · filed 2023-04-26 | -$25.92M derived: sum of 3 quarters · filed 2023-04-26 | -$41.52M 20-F · filed 2023-04-26 | -$41.84M 10-K · filed 2022-03-28 |
| 2021-09-30 | -$6.89M 10-Q · filed 2022-11-14 | -$14.87M derived: sum of 2 quarters · filed 2022-11-14 | -$30.47M 10-Q · filed 2022-11-14 | -$46.93M derived: sum of 4 quarters · filed 2023-04-26 | |
| 2021-06-30 | -$7.98M 10-Q · filed 2022-08-12 | -$23.57M 10-Q · filed 2022-08-12 | -$40.04M derived: sum of 3 quarters · filed 2023-04-26 | -$58.70M derived: sum of 4 quarters · filed 2023-04-26 | |
| 2021-03-31 | -$15.60M 10-Q · filed 2022-05-12 | -$32.06M derived: sum of 2 quarters · filed 2023-04-26 | -$50.72M derived: sum of 3 quarters · filed 2023-04-26 | -$59.61M derived: sum of 4 quarters · filed 2023-04-26 | |
| 2020-12-31 | -$16.46M derived: 20-F 12 month − 10-Q 9 month · filed 2023-04-26 | -$35.12M derived: sum of 2 quarters · filed 2023-04-26 | -$44.01M derived: sum of 3 quarters · filed 2023-04-26 | -$52.78M 20-F · filed 2023-04-26 | -$51.53M 10-K · filed 2021-03-30 |
| 2020-09-30 | -$18.66M 10-Q · filed 2021-11-12 | -$27.55M derived: sum of 2 quarters · filed 2021-11-12 | -$36.32M 10-Q · filed 2021-11-12 | -$48.50M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | -$8.89M 10-Q · filed 2021-08-12 | -$17.66M 10-Q · filed 2021-08-12 | -$29.84M derived: sum of 3 quarters · filed 2021-08-12 | -$40.48M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$8.77M 10-Q · filed 2021-05-13 | -$20.95M derived: sum of 2 quarters · filed 2021-05-13 | -$31.59M derived: sum of 3 quarters · filed 2021-05-13 | -$47.40M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | -$12.18M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$22.82M derived: sum of 2 quarters · filed 2021-03-30 | -$38.63M derived: sum of 3 quarters · filed 2021-03-30 | -$46.96M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$10.64M 10-Q · filed 2020-11-09 | -$26.45M derived: sum of 2 quarters · filed 2020-11-09 | -$34.78M 10-Q · filed 2020-11-09 | -$43.80M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | -$15.81M 10-Q · filed 2020-08-10 | -$24.14M 10-Q · filed 2020-08-10 | -$33.16M derived: sum of 3 quarters · filed 2020-08-10 | -$41.87M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$8.32M 10-Q · filed 2020-05-11 | -$17.35M derived: sum of 2 quarters · filed 2020-05-11 | -$26.06M derived: sum of 3 quarters · filed 2020-05-11 | ||
| 2018-12-31 | -$9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$17.73M derived: sum of 2 quarters · filed 2020-03-16 | -$27.19M 10-K · filed 2020-03-16 | ||
| 2018-09-30 | -$8.71M 10-Q · filed 2019-11-12 | -$18.17M 10-Q · filed 2019-11-12 |